tirofiban has been researched along with Deficiency of GP 2b 3a Complex in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adelmeijer, J; De Groot, PG; Lisman, T; Moschatsis, S; Nieuwenhuis, HK | 1 |
| Barnard, MR; Frelinger, AL; Furman, MI; Krueger, LA; Mascelli, MA; Michelson, AD; Nakada, MT | 1 |
2 other study(ies) available for tirofiban and Deficiency of GP 2b 3a Complex
| Article | Year |
|---|---|
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Topics: Abciximab; Adult; Antibodies, Monoclonal; Blood Platelets; Cells, Cultured; Collagen; Drug Evaluation, Preclinical; Endothelium, Vascular; Eptifibatide; Extracellular Matrix; Factor VIIa; Factor X; Hemorheology; Humans; Immunoglobulin Fab Fragments; Oligopeptides; Peptides; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Prothrombin; Recombinant Proteins; Tetradecanoylphorbol Acetate; Thrombasthenia; Thrombin; Thromboplastin; Tirofiban; Tyrosine | 2003 |
GPIIb-IIIa antagonist-induced reduction in platelet surface factor V/Va binding and phosphatidylserine expression in whole blood.
Topics: Abciximab; Antibodies, Monoclonal; Blood Platelets; Collagen; Dose-Response Relationship, Drug; Eptifibatide; Factor V; Flow Cytometry; Humans; Immunoglobulin Fab Fragments; Infant, Newborn; Membrane Proteins; Peptides; Phosphatidylserines; Platelet Glycoprotein GPIIb-IIIa Complex; Protein Binding; Thrombasthenia; Thrombin; Tirofiban; Tyrosine | 2000 |